小儿先天性心脏病手术中温血与冷血心脏停搏液的随机试验
这项单中心随机对照试验比较了温血(≥34°C)与冷血(4-6°C)顺行心脏停搏液在儿童先天性心脏病手术中的效果,主要终点为术后48小时内心肌肌钙蛋白T。97例患儿随机分组(温血组49例,冷血组48例),两组肌钙蛋白释放相似(几何均值比1.07;95%CI 0.79-1.44;P=0.66),但温血组重症监护停留时间平均延长14.6小时(风险比0.52;95%CI 0.34-0.79;P=0.003)。结论认为温血心脏停搏液安全且可重复,但未提供更优的心肌保护。
要点
- 温血与冷血心脏停搏液组术后48小时肌钙蛋白T释放相似(几何均值比1.07;95%CI 0.79-1.44;P=0.66)。
- 温血组重症监护停留时间较冷血组平均延长14.6小时(风险比0.52;95%CI 0.34-0.79;P=0.003)。
- 温血组非计划再次转机手术3例,冷血组1例,可能与住院时间延长趋势相关。
核心结论
- 温血心脏停搏液在小儿心脏手术中安全且可重复,但未提供优于冷血心脏停搏液的心肌保护。
研究设计与样本
- 单中心随机对照试验,比较温血(≥34°C)与冷血(4-6°C)顺行心脏停搏液在儿童中的效果,共随机97例,温血组49例、冷血组48例,中位年龄1.2岁,59例(61%)风险调整先天性心脏病手术评分≥3,无死亡,92例随访至3个月。
主要发现
- 主要终点术后48小时心肌肌钙蛋白T两组相似(几何均值比1.07;95%CI 0.79-1.44;P=0.66)。
- 其他心脏功能指标(超声心动图、动静脉血气、血管活性药物-正性肌力药物评分、心律失常)两组亦相似。
- 温血组重症监护停留时间平均较冷血组延长14.6小时(风险比0.52;95%CI 0.34-0.79;P=0.003)。
- 总住院时间温血组较冷血组有延长趋势(风险比0.66;95%CI 0.43-1.02;P=0.060)。
- 温血组非计划再次转机手术3例,冷血组1例。
临床怎么用
- 原文结论未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Intermittent cold blood cardioplegia is commonly used in children, whereas intermittent warm blood cardioplegia is widely used in adults. We aimed to compare clinical and biochemical outcomes with these 2 methods. METHODS: A single-centre, randomized controlled trial was conducted to compare the effectiveness of warm (≥34°C) versus cold (4-6°C) antegrade cardioplegia in children. The primary outcome was cardiac troponin T over the 1st 48 postoperative hours. Intensive care teams were blinded to group allocation. Outcomes were compared by intention-to-treat using linear mixed-effects, logistic or Cox regression. RESULTS: 97 participants with median age of 1.2 years were randomized (49 to warm, 48 to cold cardioplegia); 59 participants (61%) had a risk-adjusted congenital heart surgery score of 3 or above. There were no deaths and 92 participants were followed to 3-months. Troponin release was similar in both groups [geometric mean ratio 1.07; 95% confidence interval (CI) 0.79-1.44; P = 0.66], as were other cardiac function measures (echocardiography, arterial and venous blood gases, vasoactive-inotrope score, arrhythmias). Intensive care stay was on average 14.6 h longer in the warm group (hazard ratio 0.52; 95% CI 0.34-0.79; P = 0.003), with a trend towards longer overall hospital stays (hazard ratio 0.66; 95% CI 0.43-1.02; P = 0.060) compared with the cold group. This could be related to more unplanned reoperations on bypass in the warm group compared to cold group (3 vs 1). CONCLUSIONS: Warm blood cardioplegia is a safe and reproducible technique but does not provide superior myocardial protection in paediatric heart surgery.
引用
- Stoica S, Smartt HJM, Heys R, et al. Warm versus cold blood cardioplegia in paediatric congenital heart surgery: a randomized trial. Eur J Cardiothorac Surg. 2023. PMID: 36799559. doi:10.1093/ejcts/ezad041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。